Do weight loss injections make you lose hair — and what can you do about it?

You notice extra hair in the shower three months in, here is what is happening

Picture this: you have been on treatment for around twelve weeks, progress is real, and then one morning the shower drain tells a different story. It is one of the more unsettling things people report, and the worry is understandable. The reassuring part is that dermatologists have a name for it, a mechanism, and a prognosis.

Telogen effluvium is a shift in the normal hair growth cycle caused by physical stress on the body. Under ordinary circumstances roughly 10–15% of scalp hairs are in the resting (telogen) phase at any time, waiting to fall out before new growth begins. When the body undergoes a significant stressor (rapid weight loss, surgery, illness, major dietary change) a larger proportion of hairs enter that resting phase simultaneously. The shedding follows roughly two to four months later, which is why it often appears well after treatment has started rather than immediately. The hair follicles themselves are not damaged; the cycle restarts once the stressor resolves.

A calorie deficit large enough to produce meaningful weight loss qualifies as that kind of stressor, regardless of how the deficit was achieved. GLP-1 medicines like Wegovy (semaglutide) and Mounjaro (tirzepatide) suppress appetite effectively, so food intake drops substantially in the early months of treatment. That physiological shift (not the pharmacology of the medicine) is the most likely explanation for most cases of shedding reported by people on these treatments. The causal picture around injections and hair loss is explored in more depth if you want to read further.

What clinical trial data actually recorded about hair loss on these medicines

Hair loss (alopecia) was listed as a reported side effect in clinical trials for both tirzepatide and semaglutide 2.4 mg. In the SURMOUNT-1 trial of tirzepatide, alopecia was recorded in a small proportion of participants, notably more common at the higher doses associated with greater weight loss, which fits the telogen effluvium explanation rather than a dose-dependent pharmacological effect on follicles. The NHS medicines information for tirzepatide lists hair loss among uncommon side effects.

It is worth being precise about what the trial data does and does not show. These were observational reports from participants, not controlled assessments of follicular health. The pattern (appearing months into treatment, correlating with the degree of weight reduction, resolving as weight stabilises) is consistent with the nutritional-stress mechanism. It does not point to a direct toxic effect on hair follicles from the medicine itself. Semaglutide's STEP 1 trial showed a similar picture. The mechanism of how these injections work helps explain why appetite suppression can be so marked in early treatment, and therefore why nutritional shortfalls can develop if diet is not actively managed alongside.

If you are worried about nausea or other side effects alongside shedding, the guide to nausea and sickness on weight loss injections addresses those separately. Both are worth raising with your prescriber if they are affecting your daily life. The NHS tirzepatide medicines page lists alopecia among the recognised uncommon effects of Mounjaro.

Protein, nutrition and the practical steps that genuinely help

The single most cited modifiable factor in telogen effluvium related to weight loss is protein intake. Hair is primarily keratin, a structural protein, and follicles are metabolically active tissue that competes poorly for nutrients when overall intake is low. When appetite falls sharply on a GLP-1 medicine, it is easy to eat far less than you realise, and if what you do eat skews towards small, convenient, low-protein options, the deficit compounds.

Getting enough protein each day (a registered dietitian can help set a target appropriate to your body weight and the rate of loss) is the intervention with the most evidence behind it for reducing shedding during calorie restriction. Staying well hydrated matters too, as does not skipping meals entirely. This is partly why the clinical guidance for these medicines emphasises lifestyle and nutritional support alongside the injection, not just for results, but for overall health during treatment.

Keeping your pen in the fridge and your supplement routine consistent is a small practical anchor; pairing your weekly injection with a meal-plan review each week helps build the habit of checking that nutrition is not quietly falling short. If shedding continues beyond six months or feels severe, a GP can rule out other causes such as thyroid changes or iron deficiency, which sometimes surface during a period of dietary change. If you are on omeprazole alongside your treatment, the guidance on taking omeprazole with weight loss injections is worth reading, as managing your overall medication routine carefully supports the same protein-forward approach. For broader context on body composition during treatment, the piece on muscle loss and weight loss injections addresses the related question of preserving lean mass, the same protein-forward approach applies.

When to raise it with a prescriber, and what to watch for

Temporary, diffuse shedding that peaks a few months into treatment and then gradually settles is generally consistent with telogen effluvium and does not on its own warrant stopping treatment. What is worth flagging promptly: shedding that is patchy rather than diffuse, continues beyond six months, is accompanied by scalp symptoms, or feels severe enough to be distressing. A prescriber can assess whether a dose review, a nutritional referral or investigation for an unrelated cause makes sense.

Never adjust your dose or stop treatment on your own in response to hair shedding. These are prescription medicines, and any change to how you take them should go through a clinical review. If you are considering starting treatment and want to discuss this kind of concern upfront, that is exactly what a consultation is for.

The overview of weight loss injections available in the UK is a good starting point if you are still weighing your options. Questions about cost and what a private prescription includes are answered on the treatment and pricing page. For anything specific to your situation, the team at nume includes GPhC-registered Independent Prescribers who review consultations the same day, a real clinician reads your answers, not an automated system. If you are ready to talk through your options, starting a free consultation is the next step.